YC
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit From Olaparib and Bevacizumab Maintenance in Ovarian Cancer | JCO precision oncology |  | 2025 | 11 | 24 | ||
| Reporting of somatic variants in clinical cancer care : recommendations of the Swiss Society of Molecular Pathology | Virchows Archiv | | 2024 | 54 | 73 | ||
| BRCA2 germline mutation carrier with five malignancies : a case report | Hereditary Cancer in Clinical Practice | | 2024 | 32 | 92 | ||
| High concordance of different assays in the determination of homologous recombination deficiency-associated genomic instability in ovarian cancer | JCO precision oncology | | 2024 | 113 | 95 | ||
| Normalized LST Is an Efficient Biomarker for Homologous Recombination Deficiency and Olaparib Response in Ovarian Carcinoma | JCO precision oncology | | 2023 | 110 | 111 | ||
| Ovarian cancer with high-level focal ERBB2 amplification responds to trastuzumab and pertuzumab | Gynecologic Oncology Reports | | 2021 | 259 | 115 | ||
| Automated Detection of Arm-Level Alterations for Individual Cancer Patients in the Clinical Setting | The journal of molecular diagnostics | | 2021 | 201 | 242 | ||
| Tissue-plasma TMB comparison and plasma TMB monitoring in patients with metastatic non-small cell lung cancer receiving immune checkpoint inhibitors | Frontiers in Oncology | | 2020 | 295 | 254 | ||
| Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss | Cancer Biology and Therapy | | 2020 | 353 | 161 | ||
| Targeted RNA-sequencing identifies FBXW4 instead of MGEA5 as fusion partner of TGFBR3 in pleomorphic hyalinizing angiectatic tumor | Virchows Archiv |  | 2019 | 394 | 0 | ||
| Towards optimal pancreatic cyst fluid management: the need for standardisation | Gut | | 2018 | 375 | 0 |
